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In their essay in October’s PLoS Medicine, Daniel Reidpath
and Kit Yee Chan challenge the widely cited link between
HIV-related stigma and the spread of the epidemic [1].
This is an important question, given the heavy emphasis on
stigma in policies of the World Health Organization, the Joint
United Programme on HIV/AIDS, and other public health
institutions, but in making their argument Reidpath and
Chan misrepresent the connections that other authors have
made between stigma and viral transmission, ignore evidence
that does suggest an association, and propose a model of their
own for which they offer no evidence.
HIV infection establishes itself ﬁrst in certain high-risk
groups—men who have sex with men, intravenous drug
users, sex workers, mobile populations—and only later
moves into the general population. In the early stages of the
epidemic, stigma facilitates transmission within high-risk
groups, because these already marginalized groups receive
little attention from policy makers and the health-care
community and are further discriminated against when they
are identiﬁed with HIV and AIDS [2]. Stigma also prevents
or makes it more difﬁcult for members of high-risk groups
to access preventive services, including HIV antibody testing
[3]. Reidpath and Chan distort this dynamic by describing
a model in which stigma leads to fear which leads to unsafe
behavior. We know of no one who suggests that stigma causes
sex between men or intravenous drug use. Instead, there is
evidence that HIV-related stigma makes it difﬁcult for people
to take actions to reduce their risks; for example, by accessing
HIV education [4], exchanging needles [5], and negotiating
condom use [6]. Stigma may even lead women who know
they are HIV positive to breast-feed their infants rather than
arouse suspicion of their serostatus through formula feeding
[7]. This undoubtedly increases the risk of vertical viral
transmission.
Reidpath and Chan go on to propose that stigma may
actually “slow the spread of infection from those [highrisk] groups to the general population.” Although there
is a plausible logic to this suggestion, there is no evidence
for it. Even if stigma does reduce the opportunities that
marginalized groups have to transmit HIV to the broader
population, this would have little effect on the dynamics of a
generalized epidemic.
While they recognize that stigma presents a barrier to
the treatment and care of people living with HIV, Reidpath
and Chan fail to recognize the association this may have
with increased transmission. HIV-related stigma discourages
people from disclosing their status, entering care, and
adhering to antiretroviral regimens, all of which represent
missed opportunities for prevention.
Around the world HIV capitalizes on and reinforces social
stigma and discrimination, especially the low status of women.
Defeating the epidemic requires an honest examination of all
these phenomena and interventions that target both the virus
itself and its widespread social impacts. 
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HIV, Stigma, and Rates of Infection:
A Human Rights and Public Health
Imperative
Susan Timberlake, Jason Sigurdson
In their essay “HIV, Stigma, and Rates of Infection: A Rumour
without Evidence”, Daniel Reidpath and Kit Yee Chan
rightly underscore the insufﬁcient body of research on the
relationship between stigma and discrimination and HIV
transmission [1]. Increased scientiﬁc attention and effective
programming against stigma and discrimination are both
sorely needed. But the Joint United Nations Programme on
HIV/AIDS (UNAIDS) does not accept a number of points
made in the essay.
Discrimination based on health status, including HIV, is a
human rights violation, and stigma is the social form of this
violation. HIV stigma and discrimination are wrong in and
of themselves, and should be stopped for that reason alone.
Reidpath and Chan suggest, as “an alternative hypothesis to
the UNAIDS position”, that stigma against certain groups,
including people living with HIV, may have a public health
value because it “could reduce opportunities for contact
between high- and low-risk groups”. UNAIDS cannot endorse
a hypothesis that bases a public health goal on a human rights
violation; nor do we believe it is either right, or necessary, to
pit the public health against human rights.
The right to health—and human value, dignity, and
autonomy, the bases of human rights—requires that people
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have the information, services, and support they need to
protect their health and avoid causing harm to others. So
does the public health. In this context, people living with HIV
should not and need not be social pariahs to achieve public
health goals; neither should HIV-negative people be put in
a position of “protecting themselves” through stigma against
others.
UNAIDS stands by the view that stigma and discrimination
increase vulnerability to both infection and the impact of
HIV. People, including those living with HIV, repeatedly
make clear that their fear, or real experience, of stigma and
discrimination affects whether, when, and how they take up
HIV prevention and treatment goods and services. Thus,
efforts to get people to protect themselves from getting
infected, or if infected, to ﬁnd out about their status, prevent
the onward transmission of HIV, and access treatment, are
hindered by stigma and discrimination.
UNAIDS encourages both governments and researchers
to focus on what Reidpath and Chan consider “the moredifﬁcult issues relating to the manner in which HIV spreads
in populations, the social vulnerabilities it exploits, and the
ways in which individuals…interact with each other”. But
the complexities the authors cite undermine their argument
that stigma between groups may result in a reduction of HIV
transmission. In dealing with HIV, it has become very clear that
people’s behaviour transcends population groups over time
and space. The belief that risk rests in “the other” creates a
false perception of safety and may in fact increase vulnerability.
Stigma and discrimination by governments against
particular groups, such as women, the poor, sex workers,
ethnic minorities, people who use drugs, migrants, men
who have sex with men, and prisoners, often means that
those most affected by HIV receive the least attention in the
response. This makes the national HIV response less effective
and compounds human rights violations against these people.
Contrary to the authors’ assertion that the link between
stigma and the epidemic has “become the basis for
considerable policy and program development”, very little in
fact is being done about stigma and discrimination in national
programmatic responses. This is cause for great concern,
given that stigma and discrimination have been identiﬁed as
major barriers to achieving universal access to prevention,
treatment, care, and support in all the consultations on the
subject. Will governments ﬁnally implement programmatic
responses to overcome stigma and discrimination? We believe
it is essential that they do so.
As the number of infections increase and millions still need
treatment, UNAIDS welcomes the growing body of research
on HIV stigma and discrimination. Among other things, we
are supporting people living with HIV to develop an index on
stigma and discrimination. We hope that data from this tool
will both provoke and assist governments to overcome stigma
and discrimination in their national responses to HIV. People
and governments confronting HIV should do so not out of
fear or stigma, but out of the knowledge that we all share the
same rights and protecting these rights protects us all from
HIV and AIDS. 
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HIV, Stigma, and Rates of Infection:
But Is AIDS-Related Stigma Understood?
Arachu Castro
Although its title attracted me to read this paper [1], I
was quickly disappointed. First, it advances a Malthusian
approach that applauds the “potential beneﬁts” of AIDSrelated stigma. Second, it reﬂects a poor understanding of
some of the existing literature on AIDS-related stigma cited
in the article. The authors claim that the idea that stigma
and discrimination thwart efforts to control the epidemic
and constitute barriers for prevention and treatment is
said over and over, with no evidence, “like a shibboleth,”
and cite eleven references that are meant as examples
of this uncritical repetition. Surprisingly though, at least
one of the articles cited already argues that “confusion
surrounds debate over stigma as a barrier to introducing
antiretrovirals to poor countries or to making voluntary HIV
tests accessible” and that “to assess AIDS-related stigma and
declare it a cause rather than both cause and consequence
of inequality will probably weaken efforts to address AIDS
among those with heightened risk of HIV because of poverty,
racism, and gender inequality” [2]. Finally, the authors
show limited understanding of social and sexual dynamics.
Their distinction between “subpopulations” and “the general
population” seems to imply that the former, such as the
subpopulation of sex workers, lives in isolation of the latter
and that it takes a certain amount of time for HIV to go from
one to the other; it implies, for example, that sex workers
ﬁrst transmit HIV amongst themselves and then at some
later point they transmit it to “the general population.” I
am afraid that the authors are actually conceptualizing HIV
transmission within the similar linear frameworks that they
are trying, unsuccessfully, to criticize. 
Arachu Castro (Arachu_Castro@hms.harvard.edu)
Harvard Medical School
Boston, Massachusetts, United States of America
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affects the lives of people living with HIV/AIDS. There is little
or no evidence, however, to support the notion that HIVrelated stigma is one of the determinants of the global HIV
epidemic. Furthermore, an argument could be made for why
stigma might slow or contain the spread of infection in the
general population. Given the very different effect the two
positions would have on policy and the signiﬁcance of the HIV
epidemic, they deserve investigation. Among epidemiologists,
two competing hypotheses, for which there is no strong
evidence either way, would constitute a position of equipoise.
The UNAIDS position is that HIV stigma and discrimination
is a human rights violation “and should be stopped for
that reason alone” [1]. Excellent point! Let’s do that and
understand why we are doing it. But in the absence of evidence,
do not let us conﬂate the epidemiology of the infection with
the human rights position. The letter goes on to say that
“UNAIDS cannot endorse a hypothesis that….” Of course,
we never wanted a hypothesis endorsed. We want hypotheses
tested. The original (UNAIDS) position is treated as fact, and
from the UNAIDS response, continues to be treated as a fact,
when it was (and is) simply a hypothesis. Before this or any
other hypothesis is endorsed, it should be tested.
The role of stigma is complex, carrying with it social
beneﬁts and social harms. It is a social process. By treating
it as a serious object of health research, its multiple roles,
including its role in disease propagation, can be legitimately
investigated rather than marginalized as the poster child
of advocates. Furthermore, by understanding the nature of
stigma, it may be possible to develop health interventions
that neither rely on stigma to succeed nor arbitrarily and
inappropriately declare it to be a causal agent.
Research and advocacy have important and fundamental
roles in population health. They each need to be used
appropriately. 
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HIV, Stigma, and Rates of Infection:
Absence of Evidence
Mark Seielstad
Absence of evidence is not evidence of absence. Reidpath and
Chan [1] present absolutely no reasons or data that would
undermine the hypothesis that stigmatization can increase
the risk of HIV spread in populations (nor any in favor of
their own contrary hypothesis that stigmatization could halt
the spread of HIV). More data to address the question may be
needed to establish either hypothesis, but motivations to collect
such data should not come from illogical and inﬂammatory
counterhypotheses. In the guidelines for correspondence
to PLoS Medicine, we are advised that “...letters inciting racial
hatred, sexism, or homophobia [will not be published]” [2],
but the present authors skirt the commission of such acts
very closely. After all, HIV prevalences also differ among
races, sexes, and sexual orientations, so the stigmatization of
groups with high rates of infection by those with lower rates
of infection could be viewed as helpful to the goal of HIV
containment. This seems unlikely to be helpful, and would
impose a much greater societal cost. This essay is shameful in
its intellectual dishonesty and lack of evidence to support its
own unappealing counterhypothesis. 
Mark Seielstad (mseielst@hsph.harvard.edu)
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The HIV/AIDS area has always been highly politically
and emotionally charged, and we wrote a controversial
and provocative piece. Most of the responses to it were
unreasoned. The most cogent response came from UNAIDS
(the Joint United Nations Programme on HIV/AIDS) [1],
and it generally restated an already well articulated position.
We disagree with a number of the points for the reasons
discussed in our original essay, and applaud one point.
First, a brief restatement of our argument is warranted.
There is good evidence that HIV-related stigma adversely
PLoS Medicine | www.plosmedicine.org

Noncommunicable Diseases
and Injuries: Action Needed
in South Asia Too
Ali Khan Khuwaja, Riaz Qureshi, Zafar Fatmi
We read with great interest the essay by Perel et al. [1] on
noncommunicable diseases (NCDs) and injuries in Latin
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for the whole region is questionable and translating this
research into practice is also difﬁcult.
Keeping in mind the frightening scenario of NCDs in SA
countries, the best option to tackle the epidemic is to take
earlier action through comprehensive, multifaceted, and
multicultural preventive and interventional strategies. There
is also a need for more population-based local research
on NCDs, with more collaboration and networking. These
all require innovation, funding, political will, and health
partnership between individuals, communities, clinicians,
public health practitioners, nongovernmental agencies, policy
makers and governments of the SA region. 

America and the Caribbean (LAC) countries. The authors
are to be congratulated for their excellent description of
the epidemic of NCDs and injuries in the LAC region. We
wish to comment on this growing epidemic of NCDs with
reference to South Asian (SA) countries, where the situation
is comparable to the LAC region.
South Asia, which has one quarter of the world’s
population, is experiencing a rapid epidemiological transition
similar to the LAC countries. The rising epidemic of NCDs
in the SA region is fuelled by demographic ageing and
globalization resulting in changing lifestyle, eating habits, and
working patterns with less physical activity.
In 2000, 44% of the burden of disease in this region
measured in disability-adjusted life years (DALYs) lost was
attributed to NCDs [2], and these ﬁgures are expected to rise.
Yet this growing epidemic is a neglected health issue in these
countries to a greater extent. Cardiovascular diseases are the
major contributors to premature mortality and morbidity in
the SA region. The prevalence of diabetes has risen more
rapidly in South Asia than in any region of the world. By the
year 2030, India will have the highest number of persons with
diabetes (79.4 million) [3]; similar trends are also projected
for other SA countries. Overall, prevalence of hypertension
among Pakistani adults (greater than or equal to 15 years) is
about 19% [4], and this is likely to be the pattern in other SA
countries. In South Asia, one third of the adult population
is classiﬁed as obese and the trend is also increasing in SA
children [5,6]. Large numbers of South Asians use tobacco
in various forms: it is estimated that up to 65% of all men
use tobacco in some form [7]. Tobacco use is responsible
for approximately half of the tumors in males [8]. South
Asians have one of the highest rates of oral cancers reported
worldwide, and the rates are still increasing [7,8]. Due to
the lack of reliable data and under-reporting of injuries, it is
difﬁcult to estimate their prevalence and future projections;
nevertheless, the burden is substantially high enough to be
one of the major health concerns in South Asia. In Sri Lanka
alone, a smaller SA country, road trafﬁc injuries result in
2,000 deaths and 14,000 injuries each year [9].
NCDs are expensive diseases to manage, and SA countries,
which already have poor health and economic indicators,
cannot afford this emerging costly epidemic. South Asians
have a tendency to develop cardiovascular diseases at
relatively earlier ages compared to other parts of the world,
resulting in the highest potential of loss of productive life
years. For a low-income Indian family with an adult with
diabetes, as much as 25% of family income may be devoted to
diabetes care [10].
Like the LAC region [1], SA countries have social and
cultural disparities and inequalities. People of higher
socioeconomic status and men who are the major economic
contributors of their families are usually able to access the
best available health-care facilities. As in LAC countries,
South Asians of lower socioeconomic levels have the highest
prevalence of mental health problems. The SA countries are
well-equipped with highly qualiﬁed human resources and
have common culture and languages, which can enhance
more meaningful research, but are often unable to produce
signiﬁcant levels of quality research due to lack of funding
and ﬁnancial resources. With some exceptions, much of the
research on NCDs has been descriptive or observation and on
a small scale. Hence, the generalizability of existing research
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Eight Americas: Differences in Asian
Communities Are Important
Linda Silka, Robin Toof, Dorcas Grigg-Saito
The article “Eight Americas: Investigating Mortality
Disparities across Races, Counties, and Race-Counties in the
United States” [1] reports on what the authors describe as
racial differences in mortality. The authors analyze what they
label the “eight Americas” (i.e., Asian; Northland low-income
rural white; Middle America; low-income whites in Appalachia
and the Mississippi Valley; Western Native American; Black
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Middle America; Southern low-income rural black; high-risk
urban black). In contrast to other races, “Asian” is treated
as a single homogenous category. Income and geographical
differences are not considered. The authors point out that
they have likely collapsed across differences with the “Asian”
category, but they go on to report their results as if such
differences are inconsequential. They are not. With regard to
health disparities, such differences are particularly important.
Consider recent ﬁndings that speak to health differences
within the nominal category of “Asian.” As a part of the
Center for Disease Control and Prevention’s Racial and
Ethnic Approaches to Community Health (REACH) 2010
program [2], a survey was conducted in 2001–2002 with a
sample of Vietnamese in several counties in California and
Cambodians in Lowell, Massachusetts (the second largest
Cambodian community in the US). Comparing the results to
the national 2002 Behavior Risk Factor Surveillance System
survey that aggregates all Asian responses, the Koch-Weser
et al. data indicate that the educational level and income of
Cambodians and Vietnamese were substantially lower than
all Asians, and that Cambodians and Vietnamese were three
times more likely than other Asians to not have visited a
doctor in the past year due to ﬁnancial reasons. In addition,
in comparison to all Asians or the general population, higher
proportions of Cambodian and Vietnamese men reported
smoking (50.4% and 30.4% respectively compared to 14.7% of
aggregated Asians), and Cambodian and Vietnamese of both
genders reported eating fewer vegetables (16.4% and 11.1%).
And in the case of important chronic health problems such
as diabetes, only 47.7% of Cambodians surveyed reported
having their cholesterol checked and 41.9% reported having a
hemoglobin A1c test conducted if they had diabetes.
A 2002 representative survey of Cambodian adults over age
25 in Lowell, Massachusetts [3] found that Cambodians were
more likely to report poor health than other Massachusetts
residents (9% compared to 2%). Cambodian women and
elders were much more likely to have experienced days of
poor physical health (6.5 days on average for women and
8 days those over 50). A quarter of the Cambodian elders
were symptomatic for depression, with the rate rising to 43%
among women 50 and over. Although only 6% reported
being uninsured, 23% wanted to see a doctor in the last year
but could not, and 44% did not because of transportation
problems.
In short, existing ﬁndings indicate how diverse the health
data can be within the overall category of “Asian.” The
authors are to be applauded for their recognition of how
misleading it can be to treat the categories of “blackness” or
“whiteness” in undifferentiated ways. Unfortunately they have
failed to extend that same understanding to the analysis they
select for the category of Asians. As researchers and policy
makers use the “Eight Americas” study to guide their efforts,
the result could well be misleading interpretations that do
a disservice to those very groups within the “Asian” category
who face daily struggles with signiﬁcant health problems and
poor access to health care. 

University of Massachusetts Lowell
Lowell, Massachusetts, United States of America

Dorcas Grigg-Saito
Lowell Community Health Center
Lowell, Massachusetts, United States of America

References

1. Murray CJL, Kulkarni SC, Michaud C, Tomijima N, Bulzacchelli MT, et
al. (2006) Eight Americas: Investigating mortality disparities across races,
counties, and race-counties in the United States. PLoS Med 3: e260.
doi:10.1371/journal.pmed.0030260
2. Grigg-Saito DC, Liang S, Koch-Weser S, Toof R, Pot M, et al. (2002)
Cambodian Community Health 2010: Community behavior risk factor
survey results. Lowell (MA): Lowell Community Health Center.
3. Koch-Weser S, Grigg-Saito D, Toof R, Kreth NN, Pot M, et al. (2004).
Health status of Cambodians and Vietnamese: Selected communities,
United States, 2001–2002. MMWR Morb Mortal Wkly Rep 53: 760–765.
Citation: Silka L, Toof R, Grigg-Saito D (2007) Eight Americas: Differences in Asian
communities are important. PLoS Med 4(1): e41. doi:10.1371/journal.pmed.0040041
Copyright: © 2007 Silka et al. This is an open-access article distributed under the
terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Funding: The authors received no speciﬁc funding for this article.
Competing Interests: The authors have declared that no competing interests exist.

Eight Americas: A New Deﬁnition
for “Americas”?
Howard Junca
The use of the term “Americas” in the context of this
article [1] could confuse or mislead readers from a global
audience. The authors used this term to refer to an artiﬁcial
classiﬁcation of United States (American) populations
based on sociological aspects in order to group and analyse
epidemiological information, but, Americas (plural and
generally with the deﬁnite article) does not mean such
division inside America (the United States of America in
this case), but refers to the lands and regions of the Western
hemisphere (North America, Central (or Middle) America,
and South America, including their associated islands and
regions). While it is clear that the usage of this term in the
article is not the one strictly established, e.g., for legal issues,
but instead is a part of a conceptual framework, I respectfully
consider that the usage of the term “Americas” in the title of
this article, as in other essential parts of the publication, is
imprecise and contradictory. 
Howard Junca (howard.junca@helmholtz-hzi.de)
Helmholtz-Zentrum für Infektionsforschung
Braunschweig, Germany
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Michael Bukrinsky, Dmitri Sviridov
In their Perspective published in PLoS Medicine [1], Carr
and Ory provide a fair review of our recent paper in PLoS
Biology [2]. However, we believe their commentary puts too
much emphasis on the role of low high-density lipoprotein
(HDL) cholesterol levels as a cause of atherosclerosis in
HIV-infected patients. While HDL cholesterol levels are
reduced in untreated HIV infection [3], and defects in
reverse cholesterol transport (RCT) that we reported may
well be a contributing factor to this abnormality, initiation of
antiretroviral therapy restores HDL levels [4]. Although the
development of dyslipidemia with prolonged use of anti-HIV
drugs again lowers HDL cholesterol and in addition raises
very low-density lipoprotein and low-density lipoprotein levels
[5], it is unlikely that HIV infection contributes signiﬁcantly
to these effects. Indeed, most HDL comes from the liver
and intestine, which are responsible for maintaining plasma
HDL levels [6], but neither hepatocytes nor enterocytes are
infected by HIV. Also, the number of HIV-infected cells in
treated patients is relatively low to account for any general
changes in concentration of plasma lipoproteins.
We suggest a different model that provides a simple
connection between HIV-induced impairment of the
cellular step of RCT and pathogenesis of atherosclerosis.
We propose that RCT-defective HIV-infected macrophages
contribute to development of atherosclerosis in HIV patients
by converting into foam cells and initiating plaque formation
in the vessel wall. Indeed, speciﬁc inactivation of ABCA1 in
macrophages has been shown to induce atherosclerosis in
a mouse model independently from plasma HDL level [7].
Plaque formation through this mechanism can begin even
on the background of normal HDL but would be greatly
accelerated by dyslipidemia, a condition observed in HIV
patients treated with antiretroviral therapy. Given that even
fully suppressive HAART (highly active antiretroviral therapy)
does not eliminate long-lived productive reservoirs of the
virus and that macrophages are a likely potential component
of these reservoirs [8], long-lived HIV-infected macrophages
may contribute to atherosclerotic plaque formation long
after initiation of HAART. Consistent with this hypothesis, it
was found that the majority of cardiovascular events in HIVinfected patients are “one plaque” events [9].
Therefore, several lines of evidence indirectly implicate
HIV-infected macrophages in the pathogenesis of
atherosclerosis in HIV patients. Future studies will determine
the role of HIV-induced RCT impairment in this process and
are expected to provide an understanding of the connection
between HIV infection and atherosclerosis and to identify
novel treatment targets for both diseases. 
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Mental Health in the Millennium
Development Goals: Not Ignored
Sonia Ehrlich Sachs, Jeffrey D. Sachs
In a PloS Medicine article of September 2005, J. Jaime Miranda
and Vikram Patel ask: “Achieving the Millennium Development
Goals [MDGs]: Does Mental Health Play a Role?” [1]. We agree
with their concern that “there is no health without mental
health.” However, we do not feel mental health is ignored in
the health agenda, nor do we share their pessimism about the
potential to reach the MDGs in general.
Skepticism about the success of the MDGs is based on
the poor track record of past international goals such as the
Universal Declaration of Human Rights or the Declaration of
Alma-Ata. Indeed, the MDGs were adopted with these pitfalls
in mind. Emphasis was given to setting bold but realistic
goals, with quantiﬁable, time-bound targets. For example,
the aim to “reduce by two-thirds, between 1990 and 2015,
the under-ﬁve mortality rate,” calls for a practical plan with
concrete, monitorable guideposts.
Many assessments have shown how these health goals can
be achieved over the next ten years. The fact that progress
on under-5 mortality and disease control has been too slow
and that previous goals have not been met is why the world
needs the MDGs. Without these targets that hold poor and
rich countries accountable, poor countries will miss the
benchmarks laid out in the Millennium Declaration, even
though the objectives are attainable.
The reason that the MDGs do not explicitly address
noncommunicable diseases such as cardiovascular or
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psychiatric diseases is that the MDGs focus on the gap in
health status between rich and poor countries, a gap mainly
accounted for by infectious diseases, malnutrition, and unsafe
childbirth. The goals were crafted to address these large gaps
rather than to solve all pressing health problems.
We agree that “mental illness is closely associated
with social determinants, notably poverty and gender
disadvantage, and with poor physical health, including
having HIV/AIDS and poor maternal and child health.”
About 2.6% of disability-adjusted life years in sub-Saharan
Africa are attributable to psychiatric conditions, which
is about the same proportion attributable to nutritional
deﬁciencies, or tuberculosis, or maternal complications
from childbirth [2]. There are many areas in which
governments are using MDG-based strategies to tackle
problems that are not explicitly mentioned by the MDGs,
such as electriﬁcation, road construction, increased
agricultural yields, and more.
The author’s contention that “the MDGs do not address
strengthening of health systems” is not correct, as readers of
the UN Millennium Project recommendations (http:⁄⁄www.
unmillenniumproject.org) can see. There is no chance to
achieve any health MDGs without strengthening the health
systems. Low-income countries are placing a important
emphasis on strengthening health systems in their MDGbased planning. This will provide an important foundation
for expanded access to critical mental health programs.
The authors question “national ownership” of MDGs and
therefore question their legitimacy. The MDGs are strongly
supported throughout the low-income countries, both by
civil society as well as by governments, many of whom are
developing MDG-based policies. National ownership was
vividly displayed in September 2005, when government
leaders throughout the developing world protested
vociferously and successfully a short-lived attempt of US
negotiators to remove the term “Millennium Development
Goals” from the UN 2005 World Summit agreement.
Columbia University is involved in the Millennium Village
Project, a proof of concept that the MDGs can be achieved in
rural Africa by undertaking a holistic approach of integrated
interventions in increasing food production, improving
access to health care, water, and education, and improving
infrastructure. Although the primary focus of health
intervention is prevention and treatment of the major killers
such as infectious diseases and malnutrition, we are exploring
ways to integrate mental health care within the health
systems, and we welcome practical suggestions for successful
models that merit replication. The approach focuses on
community-led development that takes into account social
determinants of mental disease, as well as accessible mental
health interventions.
The MDGs are a matter of life and death for millions of
adults and children. We must do our utmost to ensure their
success. The development and public health communities—
including mental health professionals—need to work together
and not undermine the only shared global development goals
we have. Since their adoption in the year 2000, the MDGs
have garnered support around the word. If this broad global
movement continues to gain momentum and to apply proven
solutions to our most pressing problems, the MDGs can be
achieved, and with them, so too a signiﬁcant improvement in
mental health around the world. 
PLoS Medicine | www.plosmedicine.org
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Mental Health in the Millennium Development Goals:
Authors’ Reply
We appreciate the feedback and responses generated since
the publication of our paper of September 13, 2005 [1].
It clearly fulﬁls our aim of initiating a debate around the
core issue expressed in our work—mainly how the targets
expressed in the Millennium Development Goals (MDGs)
may have the unintended consequence of relegating mental
health and noncommunicable diseases in general from the
vision of policy makers.
Using evidence on mental health in developing countries,
we argued in our paper that addressing mental health
problems is an integral part of health system interventions
aimed at achieving some of the key MDGs, a view supported
by the responses to our paper. However, we should clarify that
within the MDGs there is not a “millennium mental health
development goal” as suggested by Kasi et al [2].
Sachs and Sachs state that “the reason that the MDGs do
not explicitly address noncommunicable diseases such as
cardiovascular or psychiatric is because the MDGs focus on
the gap in health status of rich and poor countries, a gap
mainly accounted for by infectious diseases, malnutrition,
and unsafe childbirth. The goals were crafted to address these
large gaps rather than to solve all pressing health problems”
[3]
We think this assertion deserves their reassessment. It is
a common view to assume that the developing world suffers
mainly from infectious diseases. In fact, noncommunicable
diseases kill people at economically and socially productive
ages and kill them mostly in the developing world: 80% of
chronic disease deaths occur in low- and middle-income
countries [4]. Another misconception is that the epidemic of
noncommunicable diseases is still to come. That is no longer
true: it is here already [5–7]. We need an informed debate
about the health interventions needed to tackle the burden
of disease in the developing world, and one that goes beyond
the MDGs as they are currently conﬁgured.
We are delighted to learn that the Sachs are “exploring
ways to integrate mental health care within the health
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systems,” and agree that development and public health
communities—including mental health professionals—need
to work together to ensure that the MDGs can be achieved.
Explicitly tackling these mental health gaps, in parallel with
achieving the existing MDGs, would be a major achievement,
resulting in signiﬁcant improvement in mental health around
the world. 
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